ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Memorygel™ Postapproval Study For Mentor Silicone Gel-Filled Breast Implants (MemoryGelPAS)

This study is currently recruiting participants.
Verified by Kaiser Permanente, January 2008

Sponsors and Collaborators: Kaiser Permanente
Mentor Corporation
Information provided by: Kaiser Permanente
ClinicalTrials.gov Identifier: NCT00495534
  Purpose

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) occasionally requires post-approval studies to help monitor the safety, effectiveness, and reliability of the approved device for its intended use. These studies are conducted under an FDA-approved protocol with the intended purpose of gathering specific additional information about the marketed device.


Condition Intervention
Postoperative Complications
Mammaplasty
Device: Mentor MemoryGel Silicone Gel-filled breast implants

MedlinePlus related topics:   Breast Reconstruction   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Case-Only, Prospective
Official Title:   Memorygel™ Postapproval Study Of Mentor Memorygel Breast Implants In Women Undergoing Breast Augmentation Or Reconstruction

Further study details as provided by Kaiser Permanente:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment:   42900
Study Start Date:   March 2007
Estimated Study Completion Date:   December 2017

Intervention Details:
    Device: Mentor MemoryGel Silicone Gel-filled breast implants
    implantation of Mentor MemoryGel Silicone Gel-filled breast implant
Detailed Description:

As a condition of gaining access to the approved silicone gel filled breast implants, the first 41,900 women will participate in the 10 year study. In addition, there will be a concurrent control group of 1000 women with saline filled breast implants to serve as concurrent controls for assessing rheumatologic and neurologic signs and symptoms. The study methods include a baseline questionnaire, a device tracking form, a visit at one year post-op, a visit at four to six years post-op, a visit nine to ten years post-op, and the questionnaire at the time of any participants discontinuation (when possible).

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

members and nonmembers of the Kaiser Foundation Health Plan who present for implantation of the Mentor Silicone Gel-filled breast implant at a Kaiser Permanente medical facility in Northern California


Criteria

MemoryGel Breast Implant Participants

Inclusion Criteria:

Must be a woman who

  1. Is a candidate for breast augmentation with Mentor MemoryGel breast implants and is at least 22 years old (primary or revision) OR is a candidate for breast reconstruction (primary or revision) with Mentor MemoryGel breast implants.
  2. Signs an Acknowledgement of Informed Decision from the patient brochure.
  3. Signs an Informed Consent Form and an Authorization to Disclose Health Information and Release Medical Records.
  4. Completes the baseline questionnaire (as evidenced by the participant's signature on the last page of the questionnaire).
  5. Agrees to authorize return of the device(s) to Mentor if the device is explanted.
  6. Agrees via Informed Consent to comply with the study follow-up, including full participation in all follow-up questionnaires and responding to questionnaires in their entirety.
  7. Is a U.S. resident.

Exclusion Criteria:

  1. Has active infection anywhere in her body
  2. Has existing breast cancer or pre-cancer of the breast without adequate treatment for those conditions
  3. Is currently pregnant or nursing

Saline Breast Implant Control Participants

Inclusion Criteria:

  1. Is triggered as part of the selection process for concurrent controls
  2. Is a candidate for breast augmentation and is at least 18 years old (primary or revision) OR is a candidate for breast reconstruction (primary or revision) with saline breast implants.
  3. Signs an Informed Consent Form and an Authorization to Disclose Health Information and Release Medical Records.
  4. Completes the baseline questionnaire (as evidenced by the participant's signature on the last page of the questionnaire).
  5. Agrees to authorize return of the device(s) to Mentor if they are Mentor devices
  6. Agrees via Informed Consent to comply with the study follow-up, including full participation in all follow-up questionnaires and responding to questionnaires in their entirety.
  7. Is a U.S. resident.

Exclusion criteria:

  1. Has current or past, unilateral or bilateral, silicone breast implants
  2. Has active infection anywhere in her body
  3. Has existing breast cancer or pre-cancer of the breast without adequate treatment for those conditions
  4. Is currently pregnant or nursing
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00495534

Contacts
Contact: Harold R Mancusi-Ungaro, M.D.     707-571-4405     harold.mancusi-ungaro@kp.org    
Contact: Lila Schwartz, J.D.     510-65-3875     lila.schwartz@kp.org    

Locations
United States, California
Kaiser Permanente     Recruiting
      Sacramento, California, United States, 95825-2115
      Contact: Kenneth O Phillips, M.D.     916-973-7354     kenneth.o.phillips@kp.org    
      Contact: Alexander R Vento, M.D.     916-973-7353     alexander.vento@kp.org    
Kaiser Permanente     Recruiting
      Santa Rosa, California, United States, 95403
      Contact: Harold R Mancusi-Ungaro, M.D.     707-571-4405     harold.mancusi-ungaro@kp.org    
      Contact: Eric Y Lin, M.D.     707-571-4885     eric.y.lin@kp.org    
Kaiser Permanente     Recruiting
      Oakland, California, United States, 94611-5642
      Contact: Benjamin M Hornik, M.D.     510-752-6413     benjamin.hornik@kp.org    
Kaiser Permanente     Recruiting
      Napa, California, United States, 94558
      Contact: Mark A Price, M.D.     707-258-4407     mark.a.price@kp.org    
Kaiser Permanente     Recruiting
      Richmond, California, United States, 94801-3143
      Contact: Karen M Yokoo, M.D.     510-307-2519     karen.yokoo@kp.org    
      Contact: Hop N Le, M.D.     510-307-2482     hop.le@kp.org    

Sponsors and Collaborators
Kaiser Permanente
Mentor Corporation

Investigators
Study Chair:     William Strull, M.D.     Kaiser Permanente Northern California Biomedical Institutional Review Board    
  More Information

Mentor MemoryGel Home Page  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Mentor Corporation ( Ms. Nou Moua )
Study ID Numbers:   CN-07HManc-01-B
First Received:   July 2, 2007
Last Updated:   January 24, 2008
ClinicalTrials.gov Identifier:   NCT00495534
Health Authority:   United States: Institutional Review Board

Keywords provided by Kaiser Permanente:
Silicone  
Gel  
Implant  
breast  
cicatrix  

Study placed in the following topic categories:
Postoperative Complications
Cicatrix

Additional relevant MeSH terms:
Pathologic Processes

ClinicalTrials.gov processed this record on August 28, 2008




Links to all studies - primarily for crawlers